Spirulina platensis peptide-loaded nanoliposomes alleviate hepatic lipid accumulation in Male Wistar Rats by influencing redox homeostasis and lipid metabolism via the AMPK signaling pathway

Abstract

Spirulina platensis low-molecular-weight peptides (SP) have been reported to exhibit antioxidant and hepatoprotective properties. However, the limited bioavailability and solubility of SPs limit their potential applications. In this study, to examine the potential anti-obesity effects and underlying mechanisms of SPs, high-fat diet-induced nonalcoholic fatty liver disease (NAFLD) model rats were treated with SPs and SP-loaded nanoliposomes. Furthermore, hepatic biochemical parameters, inflammatory markers, histopathological changes, and genes involved in AMPK signaling were analyzed. SP-loaded nanoliposomes demonstrated a spherical shape with slower and sustained SP release. SP and SP-loaded nanoliposomes mitigated hepatic damage by lowering serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST)and increasing hepatic antioxidant enzymes, which are manifested in improving histopathological findings. In addition, and notably SP-loaded nanoliposomes downregulated lipogenic fatty acid synthase (FAS) and sterol regulatory element-binding protein-1c (SREBP-1c) in the liver. Meanwhile, an upregulation of phosphorylated AMP-activated protein kinase (P-AMPK), and lipid acid oxidation-related genes carnitine palmitoyltransferase-1 (CPT-1) and peroxisome proliferator-activated receptor alpha (PPAR-α) was found in the rat liver. This data imply that SP and SP-loaded nanoliposomes exhibit protective potential in rats against the HFD-induced NAFLD, which is mediated through the activation of the AMPK signaling pathway.